Cancer Network Podcasts

PARP Inhibitors for Ovarian Cancer

Informações:

Sinopsis

We interview two prominent ovarian cancer researchers from both sides of the Atlantic, Dr. Michael Birrer and Dr. Jonathan Ledermann, on the role of PARP inhibitors and the challenges of developing ovarian cancer therapies.